Ergomed plc Directors' Dealing (6200D)
February 01 2018 - 3:39AM
UK Regulatory
TIDMERGO
RNS Number : 6200D
Ergomed plc
01 February 2018
Ergomed Plc
("Ergomed" or the "Company")
Directors' Dealing
Ergomed, a profitable UK-based group dedicated to the provision
of specialised services to the pharmaceutical industry and the
development of new drugs, announces that on 1 February 2018, Mr
Peter George, Chairman of the Company, bought 500,000 ordinary
shares of 1p each in the Company ("Share(s)") at a price of 190p
per Share from Dr Miroslav Reljanovic, founder and Executive
Vice-Chairman of the Company. Separately, in response to excess
demand from the placing announced by the Company this morning, Dr
Miroslav Reljanovic sold an additional 2,000,000 Shares at a price
of 190p.
Following these transactions, Mr Peter George holds 776,250
shares (representing 1.8 per cent. of the Company's issued share
capital and 1.7 per cent. of the Company's issued share capital
following admission of the Placing Shares relating to the Placing
announced by the Company earlier this morning) and Dr Miroslav
Reljanovic's holding has reduced to 15,132,237 shares (representing
35.5 per cent. of the Company's issued share capital and 33.8 per
cent. of the Company's issued share capital following admission of
the Placing Shares relating to the Placing announced by the Company
earlier this morning).
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
1 Details of the person discharging managerial
responsibilities/person closely associated
---- -----------------------------------------------------------------------------
a) Name 1) Peter George
2) Dr Miroslav Reljanovic
---- ---------------------------- -----------------------------------------------
2 Reason for the notification
---- -----------------------------------------------------------------------------
a) Position/status 1) Chairman
2) Founder and Executive Vice-Chairman
---- ---------------------------- -----------------------------------------------
b) Initial notification Initial Notification
/Amendment
---- ---------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- -----------------------------------------------------------------------------
a) Name Ergomed Plc
---- ---------------------------- -----------------------------------------------
b) Legal Entity 213800BVS8I9VMC1AP84
Identifier
---- ---------------------------- -----------------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- -----------------------------------------------------------------------------
a) Description Ordinary shares of 1 pence each
of the financial
instrument,
type of instrument GB00BN7ZCY67
Identification
code
---- ---------------------------- -----------------------------------------------
b) Nature of 1) Purchase of shares
the transaction 2) Sale of shares
---- ---------------------------- -----------------------------------------------
c) Currency GBP
---- ---------------------------- -----------------------------------------------
d) Price(s) and Price(s) Volume(s)
volume(s)
---- ---------------------------- ---------------------- -----------------------
190p 500,000
--------------------------------- ---------------------- -----------------------
190p 2,500,000
--------------------------------- ---------------------- -----------------------
e) Aggregated
information 1) 500,000
- Aggregated 2) 2,500,000
volume
- Price 1) 190p
- Aggregated 2) 190p
total
1) GBP950,000.00
2) GBP4,750,000.00
---- ---------------------------- -----------------------------------------------
f) Date of the 1 February 2018
transaction
---- ---------------------------- -----------------------------------------------
g) Place of the London Stock Exchange, AIM
transaction
---- ---------------------------- -----------------------------------------------
Enquiries:
Ergomed plc Tel: +44 (0)
1483 503205
Stephen Stamp (Chief Executive
Officer)
Numis Securities Limited Tel: +44 (0)
20 7260 1000
Michael Meade / Freddie Barnfield
(Nominated Adviser)
James Black (Joint Broker)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEANAFEDSPEEF
(END) Dow Jones Newswires
February 01, 2018 04:39 ET (09:39 GMT)
Ergomed (LSE:ERGO)
Historical Stock Chart
From Apr 2024 to May 2024
Ergomed (LSE:ERGO)
Historical Stock Chart
From May 2023 to May 2024